Newamsterdam Pharma Company N.v. · NASDAQ:NAMS
Kooij Louise Frederika sold 105,000 Newamsterdam Pharma Company N.v. shares (Form 4)
Traded Jul 20, 2026 · Filed Jul 22, 2026
On Jul 20, 2026, Kooij Louise Frederika (Chief Accounting Officer) sold 105,000 Newamsterdam Pharma Company N.v. shares at an average US$30.34 for US$3.19M under a trading plan, leaving 24,353 shares. Filed Jul 22, 2026 (Form 4).
- Sold
- 105,000 shares
- Price
- US$30.34 average (US$29.96 to US$31.71)
- Value
- US$3.19M
- Holding after
- 24,353 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Ordinary Shares | Option exercise | 25,000 | US$11.90 | 49,353 | Direct |
| Jul 20, 2026 | Ordinary Shares | Option exercise | 80,000 | US$11.17 | 129,353 | Direct |
| Jul 20, 2026 | Ordinary Shares | Sale | 70,200 | US$29.96 | 59,153 | Direct |
| Jul 20, 2026 | Ordinary Shares | Sale | 31,885 | US$31.05 | 27,268 | Direct |
| Jul 20, 2026 | Ordinary Shares | Sale | 2,915 | US$31.71 | 24,353 | Direct |
Source
Related
- Newamsterdam Pharma Company N.v.
- Kooij Louise Frederika
- Newamsterdam Pharma Company N.v. shareholders
- Form 4 · Kooij Louise Frederika · Jun 24, 2026
- Form 4 · Kooij Louise Frederika · May 27, 2026
- Form 4 · Kastelein Johannes Jacob Pieter · Oct 2, 2026
- Form 4 · Davidson Michael H. · Sep 15, 2026
- Form 4 · Smither John W · Sep 9, 2026
- Form 4 · Gunning Robert William · Sep 3, 2026
- Form 4 · Kastelein Johannes Jacob Pieter · Aug 25, 2026